Cita APA

Maeda, T., Kanzaki, H., Chiba, T., Ao, J., Kanayama, K., Maruta, S., . . . Kato, N. (2019). Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma. BMC Cancer.

Chicago Style Citation

Maeda, Takahiro, et al. "Serum Fibroblast Growth Factor 19 Serves As a Potential Novel Biomarker for Hepatocellular Carcinoma." BMC Cancer 2019.

Cita MLA

Maeda, Takahiro, et al. "Serum Fibroblast Growth Factor 19 Serves As a Potential Novel Biomarker for Hepatocellular Carcinoma." BMC Cancer 2019.